Yosra A. Muhammad
Jeddah, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Discovery of novel quinazoline-sulfonamide derivatives with promising antidiabetic activity.
Journal: Frontiers in chemistry
Published: January 31, 2026
Novel NSAID Analogs Exhibit Anti-Leukemic Activity Through Modulation of Apoptotic and Survival Pathways.
Journal: International journal of molecular sciences
Published: January 10, 2026
A novel class of phenylpyrazolone-sulphonamides rigid synthetic anticancer molecules selectively inhibit the isoform IX of carbonic anhydrases guided by molecular docking and orbital analyses.
Journal: Journal of biomolecular structure & dynamics
Published: March 13, 2023
Exploring antiproliferative activities and kinase profile of ortho-substituted N-(4-(2-(benzylamino)-2-oxoethyl)phenyl)benzamides.
Journal: Chemical biology & drug design
Published: March 02, 2023
Advances in Fungal Phenaloenones-Natural Metabolites with Great Promise: Biosynthesis, Bioactivities, and an In Silico Evaluation of Their Potential as Human Glucose Transporter 1 Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: September 18, 2022
Exploring the dual effect of novel 1,4-diarylpyranopyrazoles as antiviral and anti-inflammatory for the management of SARS-CoV-2 and associated inflammatory symptoms.
Journal: Bioorganic chemistry
Published: July 23, 2022
Exploring the Activity of Fungal Phenalenone Derivatives as Potential CK2 Inhibitors Using Computational Methods.
Journal: Journal of fungi (Basel, Switzerland)
Published: March 18, 2022
SAR Probing of KX2-391 Provided Analogues With Juxtaposed Activity Profile Against Major Oncogenic Kinases.
Journal: Frontiers in oncology
Published: February 19, 2022
Insights on Cancer Cell Inhibition, Subcellular Activities, and Kinase Profile of Phenylacetamides Pending 1H-Imidazol-5-One Variants.
Journal: Frontiers in pharmacology
Published: October 13, 2021
Improving the Solubility and Oral Bioavailability of a Novel Aromatic Aldehyde Antisickling Agent (PP10) for the Treatment of Sickle Cell Disease.
Journal: Pharmaceutics
Published: June 22, 2021
An Investigation of Structure-Activity Relationships of Azolylacryloyl Derivatives Yielded Potent and Long-Acting Hemoglobin Modulators for Reversing Erythrocyte Sickling.
Journal: Biomolecules
Published: September 15, 2020
Jaceidin Flavonoid Isolated from Chiliadenus montanus Attenuates Tumor Progression in Mice via VEGF Inhibition: In Vivo and In Silico Studies.
Journal: Plants (Basel, Switzerland)
Published: July 15, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026